𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Defibrotide a promising treatment for veno-occlusive disease after liver transplantation

Book ID
120864249
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2001
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Insights into defibrotide as therapy for
Insights into defibrotide as therapy for veno-occlusive disease
✍ Jennifer R. Gamble; Mathew A. Vadas πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 62 KB

Defibrotide (DF) is a mixture of porcine-derived single-stranded phosphodiester oligonucleotides (9-80-mer; average, 50-mer) that has been successfully used to treat severe hepatic veno-occlusive disease (sVOD) with multiorgan failure (MOF) in patients who have received cytotoxic chemotherapy in pre